125 related articles for article (PubMed ID: 7758348)
1. Alterations in the IgA carbohydrate chains influence the cellular distribution of IgA1.
Mestecky J; Hashim OH; Tomana M
Contrib Nephrol; 1995; 111():66-71; discussion 71-2. PubMed ID: 7758348
[No Abstract] [Full Text] [Related]
2. O-linked oligosaccharide on IgA1 hinge region in IgA nephropathy. Fundamental study for precise structure and possible role.
Hiki Y; Horii A; Iwase H; Tanaka A; Toda Y; Hotta K; Kobayashi Y
Contrib Nephrol; 1995; 111():73-84. PubMed ID: 7758349
[No Abstract] [Full Text] [Related]
3. Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy.
Mestecky J; Tomana M; Crowley-Nowick PA; Moldoveanu Z; Julian BA; Jackson S
Contrib Nephrol; 1993; 104():172-82. PubMed ID: 8325028
[No Abstract] [Full Text] [Related]
4. Characterization of IgA1, IgA2 and secretory IgA carbohydrate chains using plant lectins.
Wold AE; Motas C; Svanborg C; Hanson LA; Mestecky J
Adv Exp Med Biol; 1995; 371A():585-9. PubMed ID: 8525995
[No Abstract] [Full Text] [Related]
5. Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins.
Moore JS; Kulhavy R; Tomana M; Moldoveanu Z; Suzuki H; Brown R; Hall S; Kilian M; Poulsen K; Mestecky J; Julian BA; Novak J
Mol Immunol; 2007 Apr; 44(10):2598-604. PubMed ID: 17275907
[TBL] [Abstract][Full Text] [Related]
6. Underglycosylation of IgA1 hinge plays a certain role for its glomerular deposition in IgA nephropathy.
Hiki Y; Kokubo T; Iwase H; Masaki Y; Sano T; Tanaka A; Toma K; Hotta K; Kobayashi Y
J Am Soc Nephrol; 1999 Apr; 10(4):760-9. PubMed ID: 10203360
[TBL] [Abstract][Full Text] [Related]
7. Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy.
Oortwijn BD; Roos A; Royle L; van Gijlswijk-Janssen DJ; Faber-Krol MC; Eijgenraam JW; Dwek RA; Daha MR; Rudd PM; van Kooten C
J Am Soc Nephrol; 2006 Dec; 17(12):3529-39. PubMed ID: 17050773
[TBL] [Abstract][Full Text] [Related]
8. Increased N-linked glycosylation leading to oversialylation of monomeric immunoglobulin A1 from patients with Sjögren's syndrome.
Basset C; Durand V; Jamin C; Clément J; Pennec Y; Youinou P; Dueymes M; Roitt IM
Scand J Immunol; 2000 Mar; 51(3):300-6. PubMed ID: 10736100
[TBL] [Abstract][Full Text] [Related]
9. O-linked oligosaccharides of the IgA1 hinge region: roles of its aberrant structure in the occurrence and/or progression of IgA nephropathy.
Hiki Y
Clin Exp Nephrol; 2009 Oct; 13(5):415-423. PubMed ID: 19365705
[TBL] [Abstract][Full Text] [Related]
10. Compositional similarity between immunoglobulins binding to asialo-, agalacto-IgA1-Sepharose and those deposited in glomeruli in IgA nephropathy.
Takatani T; Iwase H; Itoh A; Nakamura I; Hayashi M; Sakamoto H; Kamata K; Kobayashi Y; Hiki Y; Okamoto M; Higashihara M
J Nephrol; 2004; 17(5):679-86. PubMed ID: 15593035
[TBL] [Abstract][Full Text] [Related]
11. IgA nephropathy and aberrant glycosylation of tonsillar, serum and glomerular IgA1.
Hiki Y; Ito A; Yamamoto Y; Yamamoto K; Iwase H
Adv Otorhinolaryngol; 2011; 72():68-70. PubMed ID: 21865693
[TBL] [Abstract][Full Text] [Related]
12. The interaction of selective plant lectins with neuraminidase-treated and untreated IgA1 from the sera of IgA nephropathy patients.
Hashim OH; Shuib AS; Chua CT
Immunol Invest; 2001 Feb; 30(1):21-31. PubMed ID: 11419909
[TBL] [Abstract][Full Text] [Related]
13. Neuraminidase treatment abrogates the binding abnormality of IgA1 from IgA nephropathy patients and the differential charge distribution of its alpha-heavy chains.
Hashim OH; Shuib AS; Chua CT
Nephron; 2001 Dec; 89(4):422-5. PubMed ID: 11721160
[TBL] [Abstract][Full Text] [Related]
14. [Mesangial proliferative glomerulonephritis].
Yamada A
Nihon Rinsho; 2004 Oct; 62(10):1842-6. PubMed ID: 15500128
[TBL] [Abstract][Full Text] [Related]
15. O-glycosylation of serum IgD in IgA nephropathy.
Smith AC; de Wolff JF; Molyneux K; Feehally J; Barratt J
J Am Soc Nephrol; 2006 Apr; 17(4):1192-9. PubMed ID: 16510764
[TBL] [Abstract][Full Text] [Related]
16. The glycosylation of IgA produced by murine B cells is altered by Th2 cytokines.
Chintalacharuvu SR; Emancipator SN
J Immunol; 1997 Sep; 159(5):2327-33. PubMed ID: 9278322
[TBL] [Abstract][Full Text] [Related]
17. Reactivity of glomerular and serum IgA1 to jacalin in IgA nephropathy.
Hiki Y; Iwase H; Saitoh M; Saitoh Y; Horii A; Hotta K; Kobayashi Y
Nephron; 1996; 72(3):429-35. PubMed ID: 8852492
[TBL] [Abstract][Full Text] [Related]
18. Aberrantly glycosylated IgA1 in glomerular immune deposits of IgA nephropathy.
Giannakakis K; Feriozzi S; Perez M; Faraggiana T; Muda AO
J Am Soc Nephrol; 2007 Dec; 18(12):3139-46. PubMed ID: 17978312
[No Abstract] [Full Text] [Related]
19. Aberrant glycosylation in IgA nephropathy (IgAN).
Coppo R; Amore A
Kidney Int; 2004 May; 65(5):1544-7. PubMed ID: 15086888
[TBL] [Abstract][Full Text] [Related]
20. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG.
Tomana M; Matousovic K; Julian BA; Radl J; Konecny K; Mestecky J
Kidney Int; 1997 Aug; 52(2):509-16. PubMed ID: 9264010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
